Granuloma: all 82 studies
Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in ChildrenRecruitingNCT07300865Not applicable
- Effect of Laser and Sclerotic Agent in the Treatment of Oral GranulomaNot yet recruitingNCT06639230Not applicable
- MoMa Signature During GranulomatosisRecruitingNCT05916638
- Evaluation of Cryotherapy in Granuloma PyogenicumRecruitingNCT05692427Not applicable
- Factors Affecting the Endodontic Treatment OutcomeRecruitingNCT05221450
- Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma CellsRecruitingNCT04751279
- Hypercalcemia After Paraffin Oil InjectionRecruitingNCT04292288
- Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and GranulocytesRecruitingNCT00001405
- Pain Outcomes Following Intralesional Corticosteroid InjectionsCompletedNCT03630198Phase 4Results posted
- Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant CyclophosphamideTerminatedNCT02282904Phase 1/2Results posted
- Treatment of Tracheostomy GranulomasCompletedNCT02116608Phase 4Results posted
- 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
- Conservative Versus Surgical Treatment of Umbilical Pilonidal DiseaseCompletedNCT01662765Not applicableResults posted
- Comparing Xperguide vs. Conventional Methods During Percutaneous Image Guided ProceduresTerminatedNCT01287013Not applicableResults posted
- Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous DiseaseTerminatedNCT01147042Phase 4Results posted
- Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous DiseaseCompletedNCT00578643Phase 2Results posted
- Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
- Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous DiseaseTerminatedNCT00325078Phase 1/2Results posted
- PRF Membrane and Recovery After Periapical Surgery: A 3D Imaging StudyCompletedNCT06739200Not applicable
- Tyrosine Kinase 2 (TYK2) for GA and CSWithdrawnNCT06725264Phase 2
- Periapical Lesions and Immediate ImplantsCompletedNCT06521203
- TB and Sarcoidosis GranulomaCompletedNCT06396910
- Silver Nitrate Versus Topical Steroid For Umbilical GranulomaCompletedNCT06363539Phase 2
- Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination GranulomasCompletedNCT06130462Not applicable
- The Efficacy of Laser in Root Canal DisinfectionCompletedNCT05964686Phase 2
- Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)TerminatedNCT05915897
- Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma AnnulareCompletedNCT05580042Phase 1
- Comparison Of Doxycycline And Common Salt For Treatment Of Umbilical Granuloma: A Randomised Control TrialCompletedNCT05545462Not applicable
- Corticosteroid Intralesional Injection as an Alternative Treatment in Oral Pyogenic Granuloma in the Esthetic Zone.Status unknownNCT05534334Phase 2/3
- Evaluation of 41 Cases of Pediatric Granuloma AnnulareCompletedNCT05472636
- Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisCompletedNCT05415137Phase 3
- Comparison Between RCT in Single and Two Visits, With and Without Intracanal Dressing, in Apical RepairStatus unknownNCT05256667Phase 2/3
- Effectiveness of Diode Laser and Sclerotherapy in Treatment of Oral Pyogenic GranulomaCompletedNCT05099081Not applicable
- Endobronchial Ultrasound Strain Elastography in SarcoidosisStatus unknownNCT04895111
- "Outcomes of Surgical Removal of Foreign Body Granulomas"CompletedNCT04661969
- Secondary Lymphedema Due to Human Adjuvant DiseaseCompletedNCT04588493
- Postoperative Quality of Life in Treated Patients With Human Adjuvant DiseaseCompletedNCT04579744
- Tissue Microenvironment Signatures of the Mycetoma GranulomaCompletedNCT04401969
- Double Ligation and Topical Silver NitrateCompletedNCT04248101Phase 2
- IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous DiseaseCompletedNCT04136028Early Phase 1
- Vitamin D3 For CGD Patients With BCGosis/ItisCompletedNCT03984890Phase 2/3
- Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma AnnulareCompletedNCT03910543Phase 1
- Denosumab in Subjects With Giant Cell Rich Tumors of BoneStatus unknownNCT03605199Phase 2
- Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous DiseaseCompletedNCT03548818
- Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD PatientsStatus unknownNCT03547830Phase 2
- Pioglitazone Therapy for Chronic Granulomatous DiseaseTerminatedNCT03080480Phase 1/2
- Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.TerminatedNCT02926963Not applicable
- Efficacy of Nasal Spray Calcitonin on Recurrence of Aggressive Central Giant Cell GranulomaCompletedNCT02358304Phase 2
- Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous DiseaseCompletedNCT02234934Phase 1/2
- Chronic Granulomatous Disease Study in ChinaStatus unknownNCT02231996
- Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995Status unknownNCT02082353
- Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and TherapyCompletedNCT01967693
- Radiofrequency Ablation for Liver Abscesses From Chronic Granulomatous DiseaseWithdrawnNCT01851460Phase 1
- Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold GranulomasWithdrawnNCT01678053Phase 2
- Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
- Treatment of Granuloma Umbilical in Newborn BabiesCompletedNCT01567215Phase 2
- Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD)WithdrawnNCT01381003Phase 1/2
- Simple Hygiene Versus Alcohol Based Usual Care for Umbilical CordStatus unknownNCT01369251Phase 3
- Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD)Status unknownNCT01338675Phase 1/2
- Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in ChildrenCompletedNCT00927134Phase 1/2
- Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)CompletedNCT00799071Phase 2
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood CellsCompletedNCT00730314Phase 1/2
- Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination TherapyCompletedNCT00720980
- Effect of Acid Suppression With Esomeprazole on Vocal Cord GranulomasWithdrawnNCT00567658Phase 3
- Gene Therapy for Chronic Granulomatous DiseaseStatus unknownNCT00564759Phase 1/2
- UVA1 Light for Scleroderma and Similar ConditionsTerminatedNCT00476697Not applicable
- Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedNCT00470496Phase 1
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Gene Therapy for Chronic Granulomatous DiseaseTerminatedNCT00394316Early Phase 1
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
- Use of Busulfan as Conditioning Agent for a Second Stem Cell TransplantCompletedNCT00092937Phase 1
- Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
- Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00068497Not applicable
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00023959Phase 1
- Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of CareCompletedNCT00023192Phase 3
- Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous DiseaseCompletedNCT00006417Phase 2
- Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related DisordersCompletedNCT00005933
- Stem Cell Transplant Following Low-Intensity Chemotherapy to Treat Chronic Granulomatous DiseaseCompletedNCT00001765Phase 1
- Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-upCompletedNCT00001476Phase 1
- A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of ChildhoodCompletedNCT00001317Phase 4